Your browser doesn't support javascript.
loading
A phase-1 trial of linsitinib (OSI-906) in combination with bortezomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma.
Khan, Sahar; LeBlanc, Richard; Gyger, Martin; White, Darrell; Kaufman, Johnathan; Jazubowiak, Andrzej; Gul, Engin; Paul, Harminder; Le, Lisa W; Lau, Anthea; Li, Zhihua; Trudel, Suzanne.
Afiliação
  • Khan S; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.
  • LeBlanc R; Hȏspital Maisonneuve-Rosemont, Montreal, Canada.
  • Gyger M; Jewish General Hospital, Montreal, Canada.
  • White D; Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Canada.
  • Kaufman J; Winship Cancer Institute Emory University School of Medicine, Atlanta, GA, USA.
  • Jazubowiak A; Division of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL, USA.
  • Gul E; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Paul H; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Le LW; Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, Canada.
  • Lau A; Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, Canada.
  • Li Z; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Trudel S; Princess Margaret Cancer Centre Ontario Cancer Institute, Toronto, Canada.
Leuk Lymphoma ; 62(7): 1721-1729, 2021 07.
Article em En | MEDLINE | ID: mdl-33509009
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá